Literature DB >> 30078698

Monitoring asparaginase activity in middle-income countries.

Daiane Keller Cecconello1, Isabel Cristina Ribas Werlang2, Ana Paula Alegretti3, Monique Cabral Hahn4, Mariana Rodrigues de Magalhães5, Ana Paula Battistel3, Priscila Pini Zenatti6, Jose Andres Yunes6, Caroline Cabreira-Cagliari4, Ciliana Rechenmacher4, Marcelo Zubaran Goldani4, Liane Esteves Daudt7, Mariana Bohns Michalowski8.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30078698     DOI: 10.1016/S1470-2045(18)30584-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  A comparison of asparaginase activity in generic formulations of E.coli derived L- asparaginase: In-vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia.

Authors:  Hari Sankaran; Soumika Sengupta; Vaitashi Purohit; Anand Kotagere; Nirmalya Roy Moulik; Maya Prasad; Chetan Dhamne; Gaurav Narula; Shripad Banavali; Vikram Gota
Journal:  Br J Clin Pharmacol       Date:  2020-02-18       Impact factor: 4.335

2.  Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

Authors:  Sumit Gupta; Cindy Wang; Elizabeth A Raetz; Reuven Schore; Wanda L Salzer; Eric C Larsen; Kelly W Maloney; Len A Mattano; William L Carroll; Naomi J Winick; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas
Journal:  J Clin Oncol       Date:  2020-04-10       Impact factor: 44.544

Review 3.  Asparaginase: an old drug with new questions.

Authors:  Daiane Keller Cecconello; Mariana Rodrigues de Magalhães; Isabel Cristina Ribas Werlang; Maria Lucia de Martino Lee; Mariana Bohns Michalowski; Liane Esteves Daudt
Journal:  Hematol Transfus Cell Ther       Date:  2019-10-18

4.  Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center.

Authors:  Daiane Keller Cecconello; Ciliana Rechenmacher; Isabel Werlang; Priscila Pini Zenatti; Jose Andres Yunes; Ana Paula Alegretti; Claudia Lanvers-Kaminsky; Liane Esteves Daudt; Mariana Bohns Michalowski
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

5.  A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol.

Authors:  Phumin Chaweephisal; Trai Tharnpanich; Aphinya Suroengrit; Pattramon Aungbamnet; Panya Seksarn; Darintr Sosothikul; Supanun Lauhasurayotin; Kanhatai Chiengthong; Hansamon Poparn; Piti Techavichit
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

6.  Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia.

Authors:  Jasmeet Sidhu; Manash Pratim Gogoi; Praveen Agarwal; Tathagata Mukherjee; Debparna Saha; Priyanka Bose; Prakriti Roy; Yogesh Phadke; Bhatu Sonawane; Pritha Paul; Vaskar Saha; Shekhar Krishnan
Journal:  Pediatr Blood Cancer       Date:  2021-05-03       Impact factor: 3.838

7.  Shortages and price variability of essential cytotoxic medicines for treating children with cancers.

Authors:  Yehoda M Martei; Kotoji Iwamoto; Ronald D Barr; John T Wiernkowski; Jane Robertson
Journal:  BMJ Glob Health       Date:  2020-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.